FT-017

N/A

Report date: 2025/04/24 14:38:53

Base Information

Drug NameFT-017
Drug Alias NameFT-017
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCardiomyopathy, HypertrophicCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesFrontera Therapeutics (Shanghai) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesFrontera Therapeutics (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsCardiomyopathy, Hypertrophic
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A